Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Adaptive Biotechnologies Insider Sold Shares Worth $897,356, According to a Recent SEC Filing

Adaptive Biotechnologies Insider Sold Shares Worth $897,356, According to a Recent SEC Filing

MT newswireMT newswire2026/10/19 08:07
04:07 AM EDT, 10/19/2026 (MT Newswires) -- Julie Rubinstein, President and Chief Operating Officer, on October 14, 2026, sold 35,643 shares in Adaptive Biotechnologies (ADPT) for $897,356. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 377,802 shares of the company, with 377,802 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178066426000041/xslF345X05/form4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!